Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Orv Hetil ; 161(3): 103-109, 2020 Jan.
Article in Hungarian | MEDLINE | ID: mdl-31928060

ABSTRACT

Introduction: Autologous hemopoietic stem cell transplantation remains a promising therapy in certain malignant and non-malignant conditions. The procedure, however, will increase the risk of complications, most notably early and late infections. Aim: To analyze the frequency and spectrum of pathogens in early (<+100 days) post-transplant infections and to evaluate risk factors for mortality. Method: Prospectively collected data from 699 patients undergoing autologous hemopoietic stem cell transplantation between 2007 and 2014 at our center were retrospectively reviewed and analyzed. Results: The median age of 699 patients was 56 (interquartile range: 43-62) years, 54% (376) were male. 25 patients have been transferred to other centers and 19 patients were lost to follow up. Neutropenic fever occurred in 69.8% (488) of patients. In addition, 102 infectious episodes in 96 patients were identified. Most commonly bacteremia occurred (49 episodes) with a median onset of 7 (5-11) days. The majority (33/49) of bacteremias have been observed during the pre-engraftment period. Their incidence proved to be higher in patients with malignant lymphoma compared to individuals with plasma cell disorders (p = 0.0005, OR: 2.41, 95% CI: 1.49-3.99). 12 episodes of viral infections and 8 cases of proven or probable invasive mycoses have been identified. Among the 655 patients with complete follow up, 16 in-hospital deaths (2.4%) occurred, 8 of them were associated with infections. Survival was adversely affected by early infections (p = 0.0001). Conclusion: In autologous stem cell transplantation, microbiologically unconfirmed neutropenic fever is common. Documented early bacteremia, however, is infrequent. Lymphoma patients have a significantly higher chance to develop bloodstream infections compared to individuals with plasma cell disorders. Early infections decrease the chance of survival; thus, an effective prophylaxis and therapy remains of paramount importance. Orv Hetil. 2020; 161(3): 103-109.


Subject(s)
Bacterial Infections/epidemiology , Bacterial Infections/microbiology , Fever/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Neutropenia/microbiology , Transplantation, Autologous/adverse effects , Adult , Bacterial Infections/mortality , Fever/epidemiology , Humans , Hungary/epidemiology , Lymphoma , Male , Middle Aged , Neutropenia/epidemiology , Retrospective Studies
2.
Acta Microbiol Immunol Hung ; 65(4): 459-465, 2018 Dec 01.
Article in English | MEDLINE | ID: mdl-29552897

ABSTRACT

Enterobiasis is an easily recognizable and treatable disease with higher incidence among children. Based on these facts, its clinical importance is usually underestimated. This infection also occurs during adulthood and without treatment, it can cause severe complications in some rare cases. Unnoticed subclinical infection in women can lead to infertility and even to life-threatening conditions. It is also emphasized in this paper that the treatment of identified enterobiasis during pregnancy needs caution. After reviewing the current scientific literature, two gynecological cases are presented here.


Subject(s)
Enterobiasis/complications , Enterobiasis/epidemiology , Enterobius/isolation & purification , Infertility, Female/epidemiology , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/epidemiology , Animals , Anthelmintics/therapeutic use , Enterobiasis/drug therapy , Fallopian Tubes/parasitology , Fallopian Tubes/pathology , Female , Histocytochemistry , Humans , Incidence , Infertility, Female/etiology , Mebendazole/therapeutic use , Microscopy , Pregnancy
3.
Postgrad Med ; 128(8): 790-796, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27700189

ABSTRACT

OBJECTIVES: The purpose of this study was to reveal different subgroups of patients with at least moderate risk of developing diabetes in the next 10 years, based on clustering of cardiovascular risk factors. METHODS: We performed a one-center cross-sectional study of adult patients (n = 109, median age 45 years) with Findrisc score of above 11 out of 26 maximum. We included in the cluster analysis anthropometrics, lipid and carbohydrate parameters obtained in oral glucose tolerance test (OGTT), insulin, C-peptide, creatinine, C-reactive protein, liver enzymes, beta-cell function, insulin sensitivity and insulin resistance (HOMA calculations). We also evaluated the atherogenic index of plasma (AIP). RESULTS: We identified three metabolic phenotypes of patients with at least moderate Findrisc score-one 'male' (cluster AM, n = 24), and two 'female' phenotypes (cluster AW, n = 9 and cluster BW, n = 76). Men were almost homogenous for their metabolic phenotype, with lower fat percentage than women (p < .05). Most of the women (cluster BW, n = 76) presented with better metabolic pattern i.e. lower insulin resistance, lower C-reactive protein, lower degree of obesity and visceral fat rating (p < .05), despite the higher fat percentage (p < .05). Some of the women, however, (cluster AW, n = 9) presented with parameters very similar to that of men (cluster AM) and significantly higher than in cluster BW. Despite the lack of significant differences in lipid parameters among clusters, AIP was significantly lower in cluster BW (p < .05). CONCLUSION: Most of the women presented with clearly less unfavorable atherogenic risk than men. Two different phenotypes of obese women with at least moderate Findrisc score were revealed, and the level of inflammation seems to be the main discriminant factor. Larger prospective studies are required to elucidate whether those are really two different pathogenically phenotypes or if they belong to the same phenotype's continuum.


Subject(s)
Cardiovascular Diseases/epidemiology , Obesity/epidemiology , Adult , Aged , Atherosclerosis/epidemiology , Blood Glucose , Body Weights and Measures , C-Reactive Protein , Cross-Sectional Studies , Diabetes Mellitus, Type 2/epidemiology , Diet , Exercise , Female , Glucose Tolerance Test , Humans , Hypertension/epidemiology , Insulin Resistance , Lipids/blood , Male , Middle Aged , Prospective Studies , Risk Factors
4.
Orv Hetil ; 151(39): 1591-6, 2010 Sep 26.
Article in Hungarian | MEDLINE | ID: mdl-20840916

ABSTRACT

UNLABELLED: Zygomycosis (mucormycosis) is a rare, highly aggressive opportunistic fungal disease caused by saprophytic fungi, belonging to the division Zygomycota, class Zygomycetes. Patients with immunodeficiency, neutropenia, iron overload, hematological malignancies, as well as diabetics with ketoacidosis are typically affected. CASE PRESENTATION: Authors describe the case of an eighteen-year old man with poor compliance suffering from diabetes since the age of nine. He was admitted with ketoacidotic somnolence in severe general condition with unilateral periorbital erythematous edema. Though from nasal exudates gained by the fibero-endoscopic sinus surgery Methicillin-resistant Staphylococcus aureus and Pseudomas aeruginosa was cultured, amphotericin-B was administered as the medical history, clinical picture suggested presence of zygomycosis. An invasive infection caused by Rhizopus oryzae was confirmed by histology and microbiology. DISCUSSION: The combination of antifungal therapy, repeated surgical interventions and granulocyte colony-stimulating factor resulted in good clinical response. Four month after discharge he is alive and doing well.


Subject(s)
Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Diabetes Complications/drug therapy , Diabetes Complications/microbiology , Diabetes Mellitus, Type 1/complications , Zygomycosis/drug therapy , Adolescent , Diabetic Coma/complications , Granulocyte Colony-Stimulating Factor/therapeutic use , Humans , Magnetic Resonance Imaging , Male , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/isolation & purification , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Zygomycosis/complications , Zygomycosis/diagnosis
5.
Acta Microbiol Immunol Hung ; 53(2): 135-44, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16956125

ABSTRACT

The ARTEMIS Global Antifungal Susceptibility Program provides the collection of epidemiological data and the results of the fluconazole and voriconazole susceptibility testing of yeast isolates. Participating in this study, a total of 7318 clinical yeast isolates were tested from different geographical areas in Hungary in the period 2001 to 2003. The species isolated most frequently was C. albicans (68.8%), followed by C. glabrata (11.8%), C. tropicalis (5.7%) and C. krusei (4.6%). Isolates of C. albicans, C. kefyr, C. lusitaniae, C. tropicalis and C. parapsilosis were highly susceptible to fluconazole (78.9-100%). The rates of isolation of fluconazole-resistant C. glabrata and C. krusei were higher in our study than the global mean in 2001 (28.2% and 87.5% vs. 18.3% and 70.2%, respectively). Differences were detected in the distribution of fluconazole-susceptibility data of C. glabrata isolates in the different counties of Hungary: most of the resistant isolates were observed in the eastern part of the country.


Subject(s)
Candida/drug effects , Fluconazole/pharmacology , Microbial Sensitivity Tests/methods , Pyrimidines/pharmacology , Triazoles/pharmacology , Candida/isolation & purification , Candidiasis/microbiology , Humans , Image Processing, Computer-Assisted , Microscopy, Video/methods , Voriconazole
6.
Orv Hetil ; 145(50): 2507-13, 2004 Dec 12.
Article in Hungarian | MEDLINE | ID: mdl-15662750

ABSTRACT

Over recent years the clinical importance of invasive fungal infections has significantly increased. Mucormycosis refers to a rare, life threatening, opportunistic disease caused by filamentous fungi of the order Mucorales. Most frequently mucormycosis occurs in patients with ketoacidotic diabetes and in neutropenic patients with acute leukaemia. This study of fifteen patients was conducted to evaluate the clinical characteristics of invasive mucormycosis, and goal was also to propose for an early diagnosis and management as survival can only be improved by aggressive surgery and antifungal therapy. In a retrospective analysis of the biopsy and autopsy records of the Department of Pathology at Szent László Hospital between 1992-2003 were evaluated fifteen histologically documented cases of mucormycosis. The underlying diseases were hematological malignancy with neutropenia in ten cases, chronic leukaemia with neutropenia, chronic leukaemia with latent diabetes mellitus and diabetes mellitus one case each. Three cases did not belong to any typical risk group. An in vivo diagnosis was made only in four patients with a rhinocerebral manifestation. Radical necrectomy and long-term antifungal therapy cured two of them. Two patients died of a generalised infection despite therapy. None of the systemic infections could be cured. The diagnosis was made post mortem in eleven patients. Selected clinical forms of mucormycosis are illustrated with short case reports.


Subject(s)
Mucormycosis/diagnosis , Mucormycosis/therapy , Adolescent , Adult , Antifungal Agents/therapeutic use , Antineoplastic Agents/adverse effects , Autopsy , Biopsy , Dermatologic Surgical Procedures , Diabetes Complications/diagnosis , Diabetes Complications/therapy , Early Diagnosis , Fatal Outcome , Female , Fungemia/microbiology , Hematologic Neoplasms/drug therapy , Humans , Infant , Male , Middle Aged , Mucormycosis/drug therapy , Mucormycosis/etiology , Mucormycosis/surgery , Necrosis/microbiology , Necrosis/surgery , Neutropenia/complications , Retrospective Studies , Skin/microbiology , Skin/pathology , Subcutaneous Tissue/microbiology , Subcutaneous Tissue/pathology , Subcutaneous Tissue/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...